Abingworth

Venture Capital Active United Kingdom

Last updated 2026-06-18

Portfolio

2

in our dataset

Rounds participated

3

Rounds led

1

Rounds' value

$253.5M

total disclosed, rounds participated

Stages

—

Portfolio · 2

Teva Pharmaceuticals

Generic and Specialty Pharmaceuticals

Led ★ 1 round $150.0M committed Latest: 2024-04

Oral Therapeutic Options for Patients with Rare Diseases

2 rounds $103.5M committed Latest: 2015-02